Hibernicor’s Asporto // Heart Preservation Device has undergone a design upgrade improving the usability and functionality of the heart container. This improvement follows proof-of-concept testing done at the University of Minnesota Experimental Surgical Services laboratories. The Asporto device provides perfusion of cardioplegia to the donor heart using a computer-controlled peristaltic pump in a thermoelectrically cooled and insulated container. The device effectively improves the quality of the donor heart by removing metabolic waste produced by the cardiomyocytes. The Asporto device is undergoing development and testing toward FDA approval in a 510k pathway. Further information about Asporto’s design evolution can be found in the article published in the Journal of Extracorporeal Technology.

View Article PDF